6:59 PM
 | 
Sep 19, 2013
 |  BC Extra  |  Politics & Policy

GPhA petitions FDA on biosimilar names

The Generic Pharmaceutical Association requested in a Citizen's Petition that FDA allow biosimilar and interchangeable biologics to use the same international non-proprietary name (INN) as reference biologics. GPhA said requiring different INNs for biosimilars and the original biologic would "inaccurately...

Read the full 183 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$35 USD
More Info >